Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 27 | $12,897,789 |
Sells | 232 | $30,729,844 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
17 Jun 2024 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Jun 2024 | Sale | 15,000 | 9.2721 | 139,082 | D |
17 Jun 2024 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Jun 2024 | Sale | 15,000 | 9.3199 | 139,798 | D |
13 Jun 2024 17:36 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 11 Jun 2024 | Sale | 11,447 | 8.4531 | 96,763 | D |
07 Jun 2024 16:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Jun 2024 | Sale | 50,000 | 9 | 450,000 | D |
07 Jun 2024 16:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jun 2024 | Sale | 50,000 | 8.42 | 421,000 | D |
03 Jun 2024 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 30 May 2024 | Sale | 3,000 | 8.775 | 26,325 | D |
30 May 2024 18:41 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 28 May 2024 | Sale | 11,447 | 9.1677 | 104,943 | D |
16 May 2024 16:35 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 14 May 2024 | Sale | 20,054 | 10.1194 | 202,934 | D |
03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 May 2024 | Sale | 28,704 | 8.47 | 243,123 | D |
03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 May 2024 | Sale | 21,296 | 8.47 | 180,377 | D |
03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 May 2024 | Sale | 50,000 | 7.73 | 386,500 | D |
02 May 2024 17:41 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 30 Apr 2024 | Sale | 11,447 | 7.9465 | 90,964 | D |
29 Apr 2024 18:41 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 25 Apr 2024 | Sale | 3,000 | 7.6735 | 23,020 | D |
18 Apr 2024 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 17 Apr 2024 | Sale | 23,124 | 7.583 | 175,349 | D |
18 Apr 2024 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Apr 2024 | Sale | 25,000 | 7.6663 | 191,658 | D |
18 Apr 2024 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 16 Apr 2024 | Sale | 11,447 | 7.6636 | 87,725 | D |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Apr 2024 | Sale | 25,000 | 9.02 | 225,500 | I |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Apr 2024 | Sale | 40,000 | 9.02 | 360,800 | D |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Apr 2024 | Sale | 25,000 | 8.84 | 221,000 | I |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Apr 2024 | Sale | 40,000 | 8.84 | 353,600 | D |
03 Apr 2024 17:42 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 02 Apr 2024 | Sale | 11,447 | 8.8182 | 100,942 | D |
01 Apr 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 28 Mar 2024 | Sale | 25,000 | 10.1 | 252,500 | I |
01 Apr 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 28 Mar 2024 | Sale | 40,000 | 10.1 | 404,000 | D |
25 Mar 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 21 Mar 2024 | Sale | 610 | 11.3361 | 6,915 | D |
25 Mar 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 21 Mar 2024 | Sale | 7,390 | 10.6989 | 79,065 | D |
21 Mar 2024 17:38 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 19 Mar 2024 | Sale | 20,054 | 10.792 | 216,423 | D |
14 Mar 2024 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Mar 2024 | Sale | 25,000 | 11.0326 | 275,815 | D |
14 Mar 2024 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Mar 2024 | Sale | 25,000 | 10.455 | 261,375 | D |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 1,000 | 11.5621 | 11,562 | I |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 20,000 | 11.5501 | 231,002 | I |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 4,000 | 11.5648 | 46,259 | I |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 36,319 | 11.8583 | 430,682 | D |
07 Mar 2024 18:53 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 05 Mar 2024 | Sale | 20,054 | 12.0577 | 241,805 | D |
23 Feb 2024 19:22 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 22 Feb 2024 | Sale | 8,000 | 14.895 | 119,160 | D |
21 Feb 2024 17:37 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 20 Feb 2024 | Sale | 19,745 | 12.3117 | 243,095 | D |
21 Feb 2024 17:37 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 20 Feb 2024 | Sale | 309 | 13.0432 | 4,030 | D |
15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Feb 2024 | Sale | 1,067 | 10.9841 | 11,720 | D |
15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Feb 2024 | Sale | 23,933 | 10.4335 | 249,705 | D |
15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Feb 2024 | Sale | 25,000 | 9.8624 | 246,560 | D |
09 Feb 2024 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Feb 2024 | Sale | 48,272 | 9.2182 | 444,981 | D |
08 Feb 2024 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 06 Feb 2024 | Sale | 11,447 | 9.3028 | 106,489 | D |
29 Jan 2024 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 25 Jan 2024 | Sale | 8,000 | 10.3452 | 82,762 | D |
25 Jan 2024 18:13 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 23 Jan 2024 | Sale | 20,054 | 10.5756 | 212,083 | D |
18 Jan 2024 18:37 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 17 Jan 2024 | Sale | 25,000 | 10.2539 | 256,348 | D |
18 Jan 2024 18:37 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Jan 2024 | Sale | 25,000 | 10.4464 | 261,160 | D |
18 Jan 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Jan 2024 | Sale | 18,000 | 10.93 | 196,740 | D |
11 Jan 2024 18:51 | RXRX | RECURSION PHARMACEUTICALS Inc | LI DEAN Y | Director | 09 Jan 2024 | Sale | 28,038 | 13.65 | 382,719 | I |
11 Jan 2024 18:51 | RXRX | RECURSION PHARMACEUTICALS Inc | LI DEAN Y | Director | 09 Jan 2024 | Sale | 962 | 14.0282 | 13,495 | I |
11 Jan 2024 18:50 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 09 Jan 2024 | Sale | 6,303 | 13.2124 | 83,278 | D |
11 Jan 2024 18:50 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 09 Jan 2024 | Sale | 13,751 | 13.8117 | 189,925 | D |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 1,000 | 9.4939 | 9,494 | I |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 20,000 | 9.512 | 190,240 | I |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 4,000 | 9.5073 | 38,029 | I |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 30,853 | 9.4903 | 292,804 | D |
02 Jan 2024 16:58 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 28 Dec 2023 | Sale | 8,000 | 10.5817 | 84,654 | D |
28 Dec 2023 17:48 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 26 Dec 2023 | Sale | 20,054 | 10.6285 | 213,144 | D |
19 Dec 2023 19:22 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Dec 2023 | Sale | 18,000 | 9.6 | 172,800 | D |
18 Dec 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | DAR ZAVAIN | Director | 14 Dec 2023 | Sale | 20,141 | 9 | 181,269 | D |
14 Dec 2023 18:53 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Dec 2023 | Sale | 25,000 | 7.5908 | 189,770 | D |
14 Dec 2023 18:51 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 12 Dec 2023 | Sale | 11,447 | 7.3987 | 84,693 | D |
14 Dec 2023 18:53 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Dec 2023 | Sale | 25,000 | 7.3947 | 184,868 | D |
08 Dec 2023 17:22 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Dec 2023 | Sale | 59,829 | 7.4946 | 448,394 | D |
30 Nov 2023 17:41 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 28 Nov 2023 | Sale | 11,447 | 6.7195 | 76,918 | D |
17 Nov 2023 17:53 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 16 Nov 2023 | Sale | 3,000 | 6.7599 | 20,280 | D |
17 Nov 2023 17:52 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Nov 2023 | Sale | 18,000 | 6.51 | 117,180 | D |
16 Nov 2023 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 15 Nov 2023 | Sale | 4,700 | 7.6168 | 35,799 | D |
16 Nov 2023 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 15 Nov 2023 | Sale | 20,300 | 7.2506 | 147,187 | D |
16 Nov 2023 18:55 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 14 Nov 2023 | Sale | 8,885 | 6.3197 | 56,151 | D |
16 Nov 2023 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Nov 2023 | Sale | 25,000 | 6.3177 | 157,942 | D |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 1,000 | 5.137 | 5,137 | I |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 20,000 | 5.1147 | 102,294 | I |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 4,000 | 5.1411 | 20,564 | I |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 37,177 | 5.1996 | 193,306 | D |
02 Nov 2023 19:02 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 31 Oct 2023 | Sale | 8,885 | 5.2745 | 46,864 | D |
30 Oct 2023 18:26 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 26 Oct 2023 | Sale | 3,000 | 5.6283 | 16,885 | D |
19 Oct 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 17 Oct 2023 | Sale | 8,885 | 6.5822 | 58,483 | D |
18 Oct 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Oct 2023 | Sale | 18,000 | 6.3 | 113,400 | D |
12 Oct 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 11 Oct 2023 | Sale | 25,000 | 6.8525 | 171,312 | D |
12 Oct 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 10 Oct 2023 | Sale | 25,000 | 7.0705 | 176,762 | D |
06 Oct 2023 18:12 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Oct 2023 | Sale | 59,794 | 7.2085 | 431,025 | D |
05 Oct 2023 18:25 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 03 Oct 2023 | Sale | 8,885 | 7.2907 | 64,778 | D |
02 Oct 2023 18:19 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 28 Sep 2023 | Sale | 3,000 | 7.7198 | 23,159 | D |
21 Sep 2023 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 19 Sep 2023 | Sale | 8,885 | 8.3599 | 74,278 | D |
19 Sep 2023 17:50 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Sep 2023 | Sale | 18,000 | 8.66 | 155,880 | D |
14 Sep 2023 18:26 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Sep 2023 | Sale | 25,000 | 8.6927 | 217,318 | D |
14 Sep 2023 18:26 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Sep 2023 | Sale | 25,000 | 8.4253 | 210,632 | D |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 1,000 | 8.8363 | 8,836 | I |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 20,000 | 8.8348 | 176,696 | I |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 4,000 | 8.8337 | 35,335 | I |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 33,765 | 8.7835 | 296,575 | D |
07 Sep 2023 19:02 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 05 Sep 2023 | Sale | 8,885 | 8.7942 | 78,136 | D |
28 Aug 2023 18:04 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 24 Aug 2023 | Sale | 63 | 9.4532 | 596 | D |
28 Aug 2023 18:04 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 24 Aug 2023 | Sale | 2,937 | 8.639 | 25,373 | D |
24 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 22 Aug 2023 | Sale | 8,885 | 8.9118 | 79,181 | D |
17 Aug 2023 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Aug 2023 | Sale | 25,000 | 8.9007 | 222,518 | D |
17 Aug 2023 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 15 Aug 2023 | Sale | 25,000 | 9.2717 | 231,792 | D |
17 Aug 2023 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Aug 2023 | Sale | 18,000 | 9.25 | 166,500 | D |
10 Aug 2023 17:33 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 08 Aug 2023 | Sale | 3,272 | 11.7468 | 38,436 | D |
10 Aug 2023 17:33 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 08 Aug 2023 | Sale | 14,498 | 11.0255 | 159,848 | D |
04 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Aug 2023 | Sale | 4,060 | 13.3631 | 54,254 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)